International Patent: QUINOLINE COMPOUNDS THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE

GENEVA, Aug. 7 -- NEURODON CORPORATION filed a patent application (US2026/013433) for “QUINOLINE COMPOUNDS THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE”. With publication no. WO/2026/165450, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/47

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....